Ocugen Q&A: novel gene and cell therapies
Advancements in medical science have paved the way for ground-breaking treatments, such as gene therapies, which aim for solutions to genetic disorders. Among the …
Get BIO members’ views on everything from health care to biofuels and the bioeconomy. The below articles are articles and opinion editorials written by executives at BIO member companies, an exclusive benefit of BIO membership.
Advancements in medical science have paved the way for ground-breaking treatments, such as gene therapies, which aim for solutions to genetic disorders. Among the …
Respiratory syncytial virus, or RSV, innovations are big news this year—and for good reason. The biotech industry has finally cracked the code for treating …
Codagenix Q&A: Diversifying vaccination options for patients Read More »
In the vaccine delivery industry, the need for disruption is clear. Today, more than 1.5 million people globally die each year from diseases for …
Partnership has been the key to developing and delivering many of today’s most important medicines to patients. From the rapid development of COVID-19 vaccines …
In healthcare, business development (BD) is one of our most powerful tools to accelerate scientific innovation. In an industry where companies often race for …
3 key insights to fostering successful collaboration in women’s health Read More »
The biotechnology industry is one of the riskiest and the most challenging—but it is also one of the few that makes the difference between …
2022 was a challenging year for biotechnology. What’s in store for 2023? Read More »
Misinformation. Not COVID. Not heart disease. Not cancer. Misinformation. That’s what the Commissioner of the U.S. Food and Drug Administration recently declared the leading …
BIO Board Member: Biotech’s voice needs to get louder – and clearer Read More »